Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
Carl Icahn's Portfolio
|Company||Ticker||# of Shares||Change||Price||Value|
|19,304,913||$1,141.93||$22,044,859,303||History »||Related Stories »|
|ICAHN ENT DEP UTS||IEP||237,645,770||+15,896,308||$51.20||$12,167,463,424||History »||Related Stories »|
|CHENIERE ENERGY, Inc.||LNG||16,168,606||$86.93||$1,405,536,920||History »||Related Stories »|
|Occidental Petroleum||OXY||49,125,346||-36,901,925||$26.94||$1,323,436,822||History »||Related Stories »|
|Newell Rubbermaid Co.||NWL||43,704,616||$24.81||$1,084,311,523||History »||Related Stories »|
|CVR ENERGY, Inc.||CVI||71,198,718||$13.91||$990,374,168||History »||Related Stories »|
|CBC Holding Company||BHC||34,109,152||$27.27||$930,156,576||History »||Related Stories »|
|Cloud Centric, Inc.||CLDR||52,327,391||$15.94||$834,098,613||History »||Related Stories »|
|NAVISTAR INTERNATIONAL||NAV||16,729,960||$44.50||$744,483,220||History »||Related Stories »|
|FirstEnergy Corp||FE||18,967,757||$36.73||$696,685,715||History »||Related Stories »|
|Xerox Corp.||XRX||31,142,681||+2,373,446||$20.98||$653,373,448||History »||Related Stories »|
|China Health Resource, Inc. Class A||HRI||4,494,789||$128.91||$579,423,250||History »||Related Stories »|
|DANA HOLDINGS CORP.||DAN||12,036,505||$22.01||$264,923,476||History »||Related Stories »|
|Kiwa Bio-Tech Products Group Corporation||WBT||11,150,368||-791,870||$23.46||$261,587,634||History »||Related Stories »|
|DELEK US HOLDINGS, Inc.||DK||7,461,625||-3,078,255||$16.66||$124,310,673||History »||Related Stories »|
|SANDRIDGE ENERGY, Inc.||SD||4,818,832||$11.43||$55,079,250||History »||Related Stories »|
|HERBALIFE LTD.||HLF||Liquidated||History »||Related Stories »|
|TENNECO, Inc.||TEN||Liquidated||History »||Related Stories »|